Palatin Technologies, Inc. (OTCMKTS:PTNT – Get Free Report) shares crossed above its two hundred day moving average during trading on Monday . The stock has a two hundred day moving average of $20.15 and traded as high as $24.57. Palatin Technologies shares last traded at $24.57, with a volume of 274 shares traded.
Palatin Technologies Trading Down 0.8%
The company has a market cap of $980,800.00, a price-to-earnings ratio of -15.82 and a beta of -1.28. The stock has a 50 day moving average price of $24.48 and a two-hundred day moving average price of $20.29.
About Palatin Technologies
Palatin Technologies, Inc is a biopharmaceutical company focused on developing medicines that target the melanocortin receptor system, a group of receptors involved in regulating appetite, sexual function, inflammation and immune responses. The company’s research is centered primarily on peptide-based therapeutics designed to selectively activate specific melanocortin receptors.
Palatin’s lead commercial product is Vyleesi (bremelanotide), an injectable melanocortin-4 receptor agonist approved by the U.S.
Further Reading
- Five stocks we like better than Palatin Technologies
- Chips to Bots: Qualcomm’s Agentic AI Breakout
- Ciena Fell 40%—Now One Analyst Sees 50% Upside
- Energy Transfer Taps the AI Power Boom
- Viking’s Obesity Edge May Be Staying Power, Not Weight Loss
Receive News & Ratings for Palatin Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Palatin Technologies and related companies with MarketBeat.com's FREE daily email newsletter.
